Reliance Industries Limited (RIL) on Friday announced that it has acquired stake in Strand Life Sciences for ₹393 crores. “Reliance Strategic Business Ventures Limited, a wholly-owned subsidiary of Reliance Industries Limited, has acquired 2,28,42,654 equity shares of Rs.10 each of Strand Life Sciences Private Limited (Strand) for a cash consideration of ₹393 crores only,” it said in a filing.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
